No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
RDNT240719C45000
- 17.48
- 0.000.00%
15min DelayClose Jul 19 13:17 ET
17.48High17.48Low
17.48Open17.48Pre Close1 Volume0 Open Interest45.00Strike Price0.00Turnover2213.88%IV-0.22%PremiumJul 19, 2024Expiry Date17.62Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9389Delta0.0087Gamma3.58Leverage Ratio-21.8704Theta0.0000Rho3.36Eff Leverage0.0008Vega
Intraday
- 5D
- Daily
News
RadNet (NASDAQ:RDNT) Has Some Way To Go To Become A Multi-Bagger
What are the early trends we should look for to identify a stock that could multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is
RadNet, Inc. (RDNT): Is This Profitable Stock a Strong Buy Now?
Returns On Capital At RadNet (NASDAQ:RDNT) Have Hit The Brakes
RadNet, Inc. Announces Date of Its Second Quarter 2024 Financial Results Conference Call
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient
RadNet Price Target Raised to $70.00/Share From $63.00 by Truist Securities
RadNet Price Target Raised to $70.00/Share From $63.00 by Truist
Express News | Truist Securities Maintains Buy on RadNet, Raises Price Target to $70
Comments
$RadNet(RDNT.US$ Significant insider selling in June. Cant blame them.
The combination of a rather low ROE and significant use of debt is not particularly appealing. Investors should consider how a company might perform if it was unable to borrow so easily, as credit markets do change over time.
2
RadNet's high P/S ratio may be due to expectations of accelerated revenue performance. However, with revenue growth forecasted to align with the industry, the elevated P/S ratio may not be sustainable. Maintaining the current share price could be challenging unless RadNet outperforms the industry in the short term.
RadNet's CEO sees the Houston acquisition as a strong platform for growth, with potential for more acquisitions, de novo build-outs, health system partnerships, and expansion of AI and digital health solutions. The Houston market aligns with other successful RadNet core geographies.
1
Market focus is on RadNet's top line growth due to its small profit. The share price growth reflects this progress. The recent improvement in total shareholder return could indicate business improvement over time.
Read more